A prior study demonstrated that GT38 detected AD-specific tau pathology in human patient brains but not 4R tau-dominant PSP, CBD, or 3R tau-dominant PiD-tau pathology [10]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.